319 related articles for article (PubMed ID: 17869677)
1. Evaluation of uncertainty-based stopping criteria for monte carlo calculations of intensity-modulated radiotherapy and arc therapy patient dose distributions.
Vanderstraeten B; Olteanu AM; Reynaert N; Leal A; De Neve W; Thierens H
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):628-37. PubMed ID: 17869677
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo evaluation of RapidArc oropharynx treatment planning strategies for sparing of midline structures.
Bush K; Zavgorodni S; Gagne I; Townson R; Ansbacher W; Beckham W
Phys Med Biol; 2010 Aug; 55(16):4465-79. PubMed ID: 20668338
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
Lee EK; Fox T; Crocker I
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
[TBL] [Abstract][Full Text] [Related]
4. Experimental measurements and Monte Carlo simulations for dosimetric evaluations of intrafraction motion for gated and ungated intensity modulated arc therapy deliveries.
Oliver M; Gladwish A; Staruch R; Craig J; Gaede S; Chen J; Wong E
Phys Med Biol; 2008 Nov; 53(22):6419-36. PubMed ID: 18941277
[TBL] [Abstract][Full Text] [Related]
5. Comparison of dose-volume histograms of IMRT treatment plans for ethmoid sinus cancer computed by advanced treatment planning systems including Monte Carlo.
Paelinck L; Smedt BD; Reynaert N; Coghe M; Gersem WD; Wagter CD; Vanderstraeten B; Thierens H; Neve WD
Radiother Oncol; 2006 Dec; 81(3):250-6. PubMed ID: 17113671
[TBL] [Abstract][Full Text] [Related]
6. ICRU reference dose in an era of intensity-modulated radiation therapy clinical trials: correlation with planning target volume mean dose and suitability for intensity-modulated radiation therapy dose prescription.
Yaparpalvi R; Hong L; Mah D; Shen J; Mutyala S; Spierer M; Garg M; Guha C; Kalnicki S
Radiother Oncol; 2008 Dec; 89(3):347-52. PubMed ID: 18762345
[TBL] [Abstract][Full Text] [Related]
7. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study.
Verbakel WF; Cuijpers JP; Hoffmans D; Bieker M; Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):252-9. PubMed ID: 19362244
[TBL] [Abstract][Full Text] [Related]
8. Clinical comparison of head and neck and prostate IMRT plans using absorbed dose to medium and absorbed dose to water.
Dogan N; Siebers JV; Keall PJ
Phys Med Biol; 2006 Oct; 51(19):4967-80. PubMed ID: 16985281
[TBL] [Abstract][Full Text] [Related]
9. Dose to the intracranial arteries in stereotactic and intensity-modulated radiotherapy for skull base tumors.
Nieder C; Grosu AL; Stark S; Wiedenmann N; Busch R; Kneschaurek P; Molls M
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1055-9. PubMed ID: 16338100
[TBL] [Abstract][Full Text] [Related]
10. A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas.
Shaffer R; Nichol AM; Vollans E; Fong M; Nakano S; Moiseenko V; Schmuland M; Ma R; McKenzie M; Otto K
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1177-84. PubMed ID: 19560880
[TBL] [Abstract][Full Text] [Related]
11. Volumetric modulated Arc therapy and conventional intensity-modulated radiotherapy for simultaneous maximal intraprostatic boost: a planning comparison study.
Shaffer R; Morris WJ; Moiseenko V; Welsh M; Crumley C; Nakano S; Schmuland M; Pickles T; Otto K
Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):401-7. PubMed ID: 19268554
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric verification for intensity-modulated radiotherapy of thoracic cancers using experimental and Monte Carlo approaches.
Jang SY; Liu HH; Wang X; Vassiliev ON; Siebers JV; Dong L; Mohan R
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):939-48. PubMed ID: 17011466
[TBL] [Abstract][Full Text] [Related]
13. A novel method for the evaluation of uncertainty in dose-volume histogram computation.
Henríquez FC; Castrillón SV
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1263-71. PubMed ID: 18313532
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.
Fonteyne V; De Gersem W; De Neve W; Jacobs F; Lumen N; Vandecasteele K; Villeirs G; De Meerleer G
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1013-20. PubMed ID: 19386427
[TBL] [Abstract][Full Text] [Related]
15. Monte Carlo simulation of RapidArc radiotherapy delivery.
Bush K; Townson R; Zavgorodni S
Phys Med Biol; 2008 Oct; 53(19):N359-70. PubMed ID: 18758001
[TBL] [Abstract][Full Text] [Related]
16. The next step in patient-specific QA: 3D dose verification of conformal and intensity-modulated RT based on EPID dosimetry and Monte Carlo dose calculations.
van Elmpt W; Nijsten S; Mijnheer B; Dekker A; Lambin P
Radiother Oncol; 2008 Jan; 86(1):86-92. PubMed ID: 18054102
[TBL] [Abstract][Full Text] [Related]
17. Treatment planning comparison of electron arc therapy and photon intensity modulated radiotherapy for Askin's tumor of chest wall.
Jamema SV; Sharma PK; Laskar S; Deshpande DD; Shrivastava SK
Radiother Oncol; 2007 Sep; 84(3):257-65. PubMed ID: 17719111
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
19. Use of motion tracking in stereotactic body radiotherapy: Evaluation of uncertainty in off-target dose distribution and optimization strategies.
Casamassima F; Cavedon C; Francescon P; Stancanello J; Avanzo M; Cora S; Scalchi P
Acta Oncol; 2006; 45(7):943-7. PubMed ID: 16982561
[TBL] [Abstract][Full Text] [Related]
20. Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity.
Hoppe BS; Wolden SL; Zelefsky MJ; Mechalakos JG; Shah JP; Kraus DH; Lee N
Head Neck; 2008 Jul; 30(7):925-32. PubMed ID: 18302261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
